BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT ACUTE LYMPHOBLASTIC LEUKEMIA.

摘要

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of acute lymphoblastic leukemia. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a bispecific antibody that specifically binds to CD20 and CD3.